Immunitybio Inc Earnings

The next earnings date for Immunitybio Inc is November 7, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Immunitybio Inc Earnings

Report DateEstimated Earnings Per Share
11/07/2025$-0.11

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Immunitybio Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/06/2025---$-0.109.09%
05/07/2025After Market$-0.156.25%
03/17/2025After Market$-0.0838.46%
11/06/2024After Market$-0.1231.56%
08/06/2024After Market$-0.20-17.65%
05/09/2024After Market$-0.20-25.00%
03/19/2024After Market$-0.35-94.44%
11/09/2023Before Market$-0.1924.00%
08/08/2023After Market$-0.32-39.13%
05/11/2023Before Market$-0.270.00%
03/01/2023After Market$-0.27-22.73%
11/09/2022Before Market$-0.28-21.74%
08/08/2022After Market$-0.240.00%
05/10/2022After Market$-0.26-18.18%
03/01/2022After Market$-0.23-9.52%
11/12/2021After Market$-0.22-10.00%
08/12/2021After Market$-0.23-91.67%
05/14/2021After Market$-0.2148.78%
03/04/2021After Market$-0.30-66.67%
11/09/2020After Market$-0.20-11.11%
08/07/2020Before Market$-0.20-5.26%
05/11/2020After Market$-0.19-11.76%
03/25/2020After Market$-0.1620.00%
11/05/2019After Market$-0.1611.11%
08/06/2019After Market$-0.1729.17%
05/08/2019After Market$-0.224.35%
03/13/2019After Market$-0.2229.03%
11/07/2018After Market$-0.3018.92%
08/06/2018After Market$-0.357.89%
05/07/2018After Market$-0.35-2.94%
03/12/2018Before Market$-0.316.06%
11/07/2017After Market$-0.306.25%
08/07/2017After Market$-0.296.45%
05/08/2017After Market$-0.3016.67%
03/15/2017After Market$-0.2932.56%
11/10/2016After Market$-0.3913.33%
08/15/2016After Market$-0.4129.31%
05/16/2016After Market$-0.38-2.70%
03/30/2016After Market$-0.97-321.74%
11/12/2015Before Market$-0.55-450.00%
09/10/2015After Market$-1.29-892.31%

More About Immunitybio Inc

Country
USA
Full Time Employees
685

ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. ImmunityBio, Inc. is based in San Diego, California.

Immunitybio Inc Earnings” Can Refer to the Immunitybio Inc Earnings Date

Some people say “Immunitybio Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Immunitybio Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Immunitybio Inc Stock on the Earnings Date

If you own Immunitybio Inc stock (IBRX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Immunitybio Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Immunitybio Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Immunitybio Inc Earnings

You can contact us any time if you would like to ask questions about Immunitybio Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.